One of the least understood areas of HIV research is the ongoing hunt for a vaccine to prevent infection. In this episode, Jen Sarché of the San Francisco Department of Public Health, answers questions about the 505 Study, a new HIV vaccine trial being conducted by the HIV Vaccine Trials Network at the National Institutes of Health. San Francisco is one of ten nationwide sites for the 505 Study, designed to increase our understanding of the T-cell's response to infection. Jen will work with partners across the region—including the San Francisco AIDS Foundation—to raise understanding about HIV vaccines and how individuals can get involved in the search.
Continue reading "SFAF.org Podcast #62 - New HIV Vaccine Trial Begins" »
In this episode, we'll hear an edited excerpt from our recent HIVision forum entitled “Is HIV Treatment HIV Prevention?” An audience member asked our panel about possible disparities in access to Pre-Exposure Prophylaxis (PrEP). We'll hear Dr. Robert Grant's answer explaining the relationship between biomedical HIV prevention and issues of social justice and stigma.
Continue reading "SFAF.org Podcast #55 - The intersection of biomedical HIV prevention and social justice" »
In this episode, Dr. Bob Grant, Associate Professor of Medicine at UCSF and an investigator at the Gladstone Institute of Virology and Immunology, discusses the PrEP Initiative study. These trials are trying to determine whether HIV medications given to HIV negative people at higher risk of infection will help reduce the amount new infections.
Continue reading "SFAF.org Podcast #52 - HIV meds for HIV prevention? Dr. Bob Grant discusses global PrEP studies." »
In this episode, Tim Ryan, a registered nurse and the clinical services manager at
Magnet, the Foundation's gay men's sexual health clinic, talks about what Magnet's doing differently to encourage sexual health in San Francisco's gay male community and why RNA testing for HIV may reduce HIV infection rates with early diagnosis of acute HIV infection. Recent studies suggest that acute HIV infection may be responsible for up to 50% of new HIV infections in San Francisco.
Continue reading "SFAF.org Podcast #39 - Magnet finds acute HIV infection with RNA testing" »
The Centers for Disease Control released its long-awaited revision of HIV incidence in the United States as the XVII International AIDS Conference got underway in Mexico City. In this special Conference edition of the SFAF.org podcast, Foundation CEO Mark Cloutier explains the new data and the ways in which San Francisco may be bucking the national trend.
Continue reading "SFAF.org IAC Podcast - Mark Cloutier outlines the significance of the CDC's recently revised HIV numbers" »
In this episode, Tom Kennedy, a public health educator who has been working in HIV prevention in San Francisco since 1992, discusses the current state of HIV vaccine trials. Last autumn, the STEP HIV vaccine trial was halted due to safety concerns. With delays now affecting the launch of new vaccine trials, Tom answers questions about the state of HIV vaccine research and what is being done to ensure the safety of trial participants.
Continue reading "SFAF.org Podcast #34 - Tom Kennedy on the current state of HIV vaccine trials" »
In this episode, Ernest Hopkins, the Foundation's Director of Federal Affairs, discusses the local and federal response to rising HIV transmission rates among Black men who have sex with men. Ernest Hopkins will be a panelist at our May 15th HIVision Forum entitled What's Going On: HIV and Black Gay Men.
Continue reading "SFAF.org Podcast #32 - Ernest Hopkins on government response to the rising HIV transmission rate among Black MSM" »
In this episode, Mark Cloutier, Executive Director of the San Francisco
AIDS Foundation and President of Pangaea Global AIDS Foundation,
discusses a year of lessons learned in the fight against HIV and
opportunities that lie ahead in 2008 to review and revise approaches to
prevention and care, and improve popular understanding of HIV and AIDS.
Continue reading "SFAF Podcast #23 - The Year in Review with Mark Cloutier" »
In this episode Dr. Judith Auerbach, Deputy Executive Director for Science and Public Policy at the San Francisco AIDS Foundation talks defining the meaning of evidence in relation to evidence-based HIV prevention.
Continue reading "SFAF Podcast #22 - Dr. Judith Auerbach Challenges the Definition of Evidence-Based HIV Prevention" »
Just back from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Sydney, BETA editor Reilly O'Neal gives us an update on two new HIV drug classes and a new early treatment recommendation. At the Sydney Conference, Reilly joined experts and advocates from around the globe for a look at the cutting edge of HIV drug and treatment information.
Continue reading "SFAF Podcast #15 - New HIV Drug Classes and Treatment Recommendations" »
In this episode, we'll get the latest information about research on microbicides — chemical compounds now in development — that may help prevent HIV transmission. Courtney Mulhern-Pearson, a policy analyst in the San Francisco AIDS Foundation's Department of Science and Public Policy explains that although there are no HIV microbicides approved for use in humans, research may soon yield another effective tool for HIV prevention.
Continue reading "SFAF Podcast #14 - HIV Microbicides: A Science and Public Policy Update" »
Dr. Judith Auerbach, Deputy Executive Director for Science and Public Policy at the San Francisco AIDS Foundation and Dr. Steven Tierney, the AIDS Foundation's Deputy Executive Director for Programs and Services, discuss our upcoming HIVision forum, Exploring What's Positive in Gay Men's Health. The forum on July 10th will be the first in a series of three HIVision forums the AIDS Foundation will convene this year to gather experts and the community together to explore ideas and options for fighting HIV.
Continue reading "SFAF Podcast #11 - Dr. Judith Auerbach and Dr. Steven Tierney on the Upcoming HIVision Forum on Gay Men's Health" »
